Search research articles
Contact Us
Filters
Showing results (81-90 of 130) with videos related to
Page
of 13
Sort By:
Leukemia & Lymphoma
|
November 25, 2020
Safety and efficacy of navitoclax, a BCL-2 and BCL-X<sub>L</sub> inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study
Sven de Vos, John P Leonard, Jonathan W Friedberg, et al.
The American Journal of Surgical Pathology
|
April 15, 2011
Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma
Joo Y Song, Franziska C Eberle, Liqiang Xi, et al.
Oncotarget
|
February 26, 2015
Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma
Violetta V Leshchenko, Pei-Yu Kuo, Zewei Jiang, et al.
The American Journal of Surgical Pathology
|
September 28, 2010
Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression
Haipeng Shao, Liqiang Xi, Mark Raffeld, et al.
Leukemia & Lymphoma
|
June 24, 2017
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R
Catherine Lai, Mark Roschewski, Christopher Melani, et al.
Frontiers in Pediatrics
|
March 16, 2017
DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in Presentation
Victoria R Dimitriades, Vincent Devlin, Stefania Pittaluga, et al.
Blood
|
July 16, 2014
A prospective study of mediastinal gray-zone lymphoma
Wyndham H Wilson, Stefania Pittaluga, Alina Nicolae, et al.
The American Journal of Surgical Pathology
|
October 17, 2014
Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations
Joo Y Song, Stefania Pittaluga, Kieron Dunleavy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2010
Circulating serum free light chains as predictive markers of AIDS-related lymphoma
Ola Landgren, James J Goedert, Charles S Rabkin, et al.
Leukemia & Lymphoma
|
February 3, 2025
Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 130) with videos related to
Sort By:
Page
of 13
Leukemia & Lymphoma
|
November 25, 2020
Safety and efficacy of navitoclax, a BCL-2 and BCL-X<sub>L</sub> inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study
Sven de Vos, John P Leonard, Jonathan W Friedberg, et al.
The American Journal of Surgical Pathology
|
April 15, 2011
Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma
Joo Y Song, Franziska C Eberle, Liqiang Xi, et al.
Oncotarget
|
February 26, 2015
Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma
Violetta V Leshchenko, Pei-Yu Kuo, Zewei Jiang, et al.
The American Journal of Surgical Pathology
|
September 28, 2010
Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression
Haipeng Shao, Liqiang Xi, Mark Raffeld, et al.
Leukemia & Lymphoma
|
June 24, 2017
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R
Catherine Lai, Mark Roschewski, Christopher Melani, et al.
Frontiers in Pediatrics
|
March 16, 2017
DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in Presentation
Victoria R Dimitriades, Vincent Devlin, Stefania Pittaluga, et al.
Blood
|
July 16, 2014
A prospective study of mediastinal gray-zone lymphoma
Wyndham H Wilson, Stefania Pittaluga, Alina Nicolae, et al.
The American Journal of Surgical Pathology
|
October 17, 2014
Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations
Joo Y Song, Stefania Pittaluga, Kieron Dunleavy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2010
Circulating serum free light chains as predictive markers of AIDS-related lymphoma
Ola Landgren, James J Goedert, Charles S Rabkin, et al.
Leukemia & Lymphoma
|
February 3, 2025
Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Page
of 13